Effects of new quinolone antibacterial agents on mammalian chromosomes

Journal of Toxicology and Environmental Health

Volumn 47, Issue 2, 1996, Pages 115-124

  Shimada, Hiroyasu ^a   Itoh, Satoru ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DU 6668; DV 7287; ENOXACIN; LEVOFLOXACIN; NALIDIXIC ACID; OFLOXACIN; PIPEMIDIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SITAFLOXACIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA REPAIR; GENOTOXICITY; HAMSTER; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL; LUNG ALVEOLUS CELL; MALE; MICRONUCLEUS TEST; MOUSE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; TOXICOKINETICS; UNSCHEDULED DNA SYNTHESIS;

ANIMALS; ANTI-INFECTIVE AGENTS; CELL LINE; CHROMOSOME ABERRATIONS; CRICETINAE; CRICETULUS; DNA REPAIR; FLUOROQUINOLONES; MALE; MICE; MICRONUCLEUS TESTS; MUTAGENS; RATS; RATS, INBRED F344;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; MAMMALIA;

EID: 0030049658     PISSN: 00984108     EISSN: None     Source Type: Journal    
DOI: 10.1080/009841096161825     Document Type: Article

References (15)

1. Bredberg, A., Brant, M., Riesbeck, K., Azou, Y., and Forsgren, A. 1989. 4-Quinolone antibiotics: Positive genotoxic screening tests despite an apparent lack of mutation induction. Mutat. Res. 211:171-180.
2. Butterworth, B. E., Ashby, J., Bermudez, E., Casciano, D., Mirsalis, J., Probst, G., and Williams, G. 1987. A protocol and guide for the in vivo rat hepatocyte DNA-repair assay. Mutat. Res. 189:123-133.
3. Gootz, T. D., Barrett, J. F., Holden, H. E., Ray, V. A., and McGuirk, P. R. 1990. Selective toxocity: the activities of 4-quinolones against eukaryotic DNA topoisomerases. In The 4-quinolones: Antibacterial agents in vitro, ed. G. C. Coumplin, pp. 159-172. Berlin: Springer-Verlag.
4. Holden, H. E., Barrett, J. F., Huntington, C. M., Muehlbauer, P. A., and Wahrenburg, M. G. 1989. Genetic profile of a nalidixic acid analog: A model for the mechanism of sister chromatid exchange induction. Environ. Mol. Mutagen. 13:238-252.
5. Kastenbaum, K., and Bowman, K. 1970. Tables for determining the statistical significance of mutation frequencies. Mutat. Res. 9:527-549.
6. McQueen, C. A., and Williams, G. M. 1987. Effects of quinolone antibiotics in test for genotoxicity. Am. J. Med. 82:94-96.
7. McQueen, C. A., Way, B. M., Queener, S. M., Schluter, G., and Williams, G. M. 1991. Study of potential in vitro and in vivo genotoxicity in hepatocytes of quinolone antibiotics. Toxicol. Appl. Pharmacol. 111:255-262.
8. Mirsalis, J. C., and Butterworth, B. E. 1980. Detection of unscheduled DNA synthesis in hepatocytes isolated from rats treated with genotoxic agents: An in vivo/in vitro assay for potential carcinogens and mutagens. Carcinogenesis 1:621-625.
9. Shen, L. L., and Pernet, A. G. 1985. Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: The target of the drug is DNA. Proc. Natl. Acad. Sci. USA 82:307-311.
10. Shen, L. L., Kohlbrenner, W. E., Weigl, W., and Baranowski, J. 1989. Mechanism of quinolone inhibition of DNA gyrase. J. Biol. Chem. 264:2973-2978.
11. Shimada, H., Ebine, Y., Kurosawa, Y., and Arauchi, T. 1984. Mutagenicity studies of DL-8280, a new antibacterial drug. Chemotherapy 32:1162-1170.
12. Shimada, H., Ebine, Y., Sato, T., Kurosawa, Y., and Arauchi, T. 1985. Dominant lethal study in male mice treated with ofloxacin, a new antimicrobial drug. Mutat. Res. 144:51-55.
13. Shimada, H., Itoh, S., Hattori, C., Tada, S., and Matsuura, Y. 1992. Mutagenicity of levofloxacin, a new quinolone antibacterial agent. Arzeneim. Forsch. 42:378-385.
14. Tornaletti, S., and Pedrini, A. M. 1988. Studies on the interaction of 4-quinolones with DNA by DNA unwinding experiments. Biochem. Biophys. Acta. 949:279-287.
15. Williams, G. M. 1977. The detection of chemical carcinogens by unscheduled DNA synthesis in rat liver primary cell cultures. Cancer Res. 37:1845-1851.